One of the main problems in interpreting the literature concerning infectious complications of CVCs is the inconsistent use of terms and definitions. Furthermore, it is often unclear exactly how the ...

Researchers at the University of Michigan reviewed scientific literature and gathered a group of experts to create The Michigan Appropriateness Guide for Intravenous Catheters, which determines ...

Please provide your email address to receive an email when new articles are posted on . Patients with severe thrombocytopenia who did not receive prophylactic transfusion before catheter placement had ...

Background: A significant decrease in catheter-related infections was demonstrated in our earlier randomized controlled trial of central venous catheter (CVC) care in hematologic patients. Objective: ...

Bone mineral density in childhood cancer survivors (CCS). Background: The aims of this prospective randomized study were two-fold: To estimate the incidence of overall venous thrombosis (VT) including ...

Catheter-related bloodstream infections are associated with recognized morbidity and mortality. Accurate diagnosis of such infections results in proper management of patients and in reducing ...

Central venous catheters (CVCs) help deliver medication, fluids, blood, or nutrition. They can also be useful for monitoring and performing certain tests and procedures. Placing CVCs or central lines ...

With a central venous catheter, you basically have a direct line from the outside world right to your heart. That’s great for getting treatment, but it means you have to manage it very carefully.

DefenCath is intended for instillation into central venous catheters only. DefenCath ® (taurolidine and heparin) catheter lock solution is now available for inpatient use to reduce the incidence of ...

The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...